from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0246/-

LFCtreatmentdescriptionclass of inhibitor

-0.305

Amikacinug/mL Amikacintranslation

0.384

Cap5-10ug/mL Capreomycintranslation

0.200

Rox10-50 ug/mL Roxithromycintranslation

1.334

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

1.039

Rif0.2-5ug/mL Rifampicintranscription

0.110

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.731

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.008

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.469

CPZ10-50 ug/mL Chlorpromazinerespiration

0.587

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.542

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.998

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.601

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.370

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.128

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.252

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.040

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.368

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.246

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.238

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.032

Nigericin50 uM Nigericinrespiration

-0.286

TRC10-150 ug/mL Triclosanrespiration

0.486

TRZ10-25 ug/mL Thioridazinerespiration

-0.747

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.443

menadione6-10 ug/mL Menadionerespiration

-0.396

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.499

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.590

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.045

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.472

NRP_1Non-replicating persistence stage 1dosRassociated

0.027

Amp0.2mg/mL AmpicillincellWall

-0.240

Cephalexin20-100 ug/mL CephalexincellWall

0.641

Cerulenin0.32-5 ug/mL CerulenincellWall

0.000

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.649

EMB10-20 ug/mL EthambutolcellWall

0.121

Eta12-40 ug/mL EthionamidecellWall

0.453

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.177

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.135

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.520

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.724

BZA0.12 mg/mL BenzamidearomaticAmides

0.434

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.293

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.923

H2O24 mM hydrogen peroxideDNAdamaging

-0.312

Levo10 ug/mL LevofloxacinDNAdamaging

1.320

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.423

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.281

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.227

UVUV-irradiationDNAdamaging

0.166

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.314

Antimycin12.5-50 ug/mL Antimycin A?

-1.813

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.028

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.644

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.018

PA8240.2-2 ug/mL PA-824?

-0.531

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.382

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.133

Verapamil50 uM Verapamil?

-1.454

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.291

methoxatin10-20 ug/mL Methoxatin?